ALS’s Investment in Nuvisan

Greenberg Traurig advised ALS Limited on the deal. ALS Limited (ALS) announced the acquisition of a 49 percent equity investment in Nuvisan Group (Nuvisan). Going forward, Nuvisan...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here